Research Article
Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis
Table 3
Subgroup analysis based on characteristics of various studies.
| Variables | T/P | Overall survival | HR (95% CI) | -squared (%) | Model | -He | value | value |
| Overall | 5/605 | 2.77 (1.80, 4.27) | 51.7 | Random effect | 0.066 | 4.61 | <0.001 | Ethnicity | | | | | | | | Asian | 3/439 | 3.78 (2.47, 5.78) | 0.0 | Fixed effect | 0.60 | 6.13 | <0.001 | Non-Asian | 2/166 | 1.68 (1.14, 2.48) | 0.0 | Fixed effect | 0.35 | 2.63 | 0.009 | Fuhrman grades III-IV (%) | | | | | | | | >70 | 1/62 | 1.48 (0.93, 2.37) | NA | NA | NA | 1.64 | 0.102 | ≤70 | 4/543 | 3.26 (2.27, 4.67) | 0.0 | Fixed effect | 0.471 | 6.41 | <0.001 | Median follow-up (months) | | | | | | | | >60 | 2/329 | 2.70 (1.73, 4.21) | 0.0 | Fixed effect | 0.727 | 4.39 | <0.001 | ≤60 | 3/276 | 3.10 (1.24, 7.80) | 78.6 | Random effect | 0.009 | 2.41 | 0.016 |
|
|
T/P: number of trials/number of patients, -He: value of heterogeneity.
|